RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in RenovoRx, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −2 vs. Q3 2023
- Shares held
- 331.2K
- −32.5K (−8.9%) vs. Q3 2023
- Total value
- $758.1K
- +$284.6K (+60.1%) vs. Q3 2023
- New holders
- 4
- 3 more added
- Sold out
- 6
- 1 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNXT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $9.00M |
| Q1 2026 | 31 | $8.58M |
| Q4 2025 | 33 | $6.83M |
| Q3 2025 | 31 | $9.04M |
| Q2 2025 | 25 | $11.6M |
| Q1 2025 | 27 | $9.98M |
| Q4 2024 | 18 | $1.31M |
| Q3 2024 | 13 | $2.00M |
| Q2 2024 | 17 | $1.01M |
| Q1 2024 | 10 | $441.6K |
| Q4 2023 | 12 | $758.1K |
| Q3 2023 | 14 | $473.5K |
| Q2 2023 | 9 | $552.2K |
| Q1 2023 | 12 | $9.64M |
| Q4 2022 | 11 | $2.75M |
| Q3 2022 | 13 | $2.49M |
| Q2 2022 | 11 | $2.35M |
| Q1 2022 | 12 | $482.0K |
| Q4 2021 | 9 | $506.0K |
| Q3 2021 | 8 | $1.02M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding RenovoRx, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nixon Peabody Trust Co | 97,165 | $222.5K | 0.02% | +97,165 | New |
| Vanguard Group Inc | 56,578 | $129.6K | 0.00% | −18,155−24.3% | Reduced |
| Geode Capital Management, LLC | 55,759 | $127.7K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 49,232 | $112.7K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 21,388 | $49.0K | 0.00% | +6,054+39.5% | Added |
| State Street Corp | 18,852 | $43.2K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 14,041 | $32.0K | 0.00% | +14,041 | New |
| Affinity Capital Advisors, LLC | 13,279 | $30.4K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,599 | $10.5K | 0.00% | +2,390+108.2% | Added |
| Bank of America Corp | 118 | $270 | 0.00% | +118 | New |
| Wells Fargo & Company | 67 | $153 | 0.00% | +6+9.8% | Added |
| Royal Bank of Canada | 101 | $0 | 0.00% | +101 | New |
| Cohen Lawrence B | 0 | $0 | 0.00% | −97,165−100.0% | Sold out |
| Level Four Advisory Services, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −11,481−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,340−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −176−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −9−100.0% | Sold out |